The distribution of apolipoprotein e genotype over the adult lifespan and in relation to country of birth

American Journal of Epidemiology

Volumn 181, Issue 3, 2015, Pages 214-217

  Kern, Silke ^a,b   Mehlig, Kirsten ^b   Kern, Jürgen ^a   Zetterberg, Henrik ^b,c   Thelle, Dag ^d   Skoog, Ingmar ^a   Lissner, Lauren ^b   Blennow, Kaj ^b   Börjesson Hanson, Anne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; BIOCHEMISTRY; EPIDEMIOLOGY; GENOTYPE; LIFE CYCLE; PROTEIN;

ADULT; AGED; APOE GENE; ARTICLE; BALTIC STATES; BIRTH; DENMARK; FINLAND; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIFESPAN; NORWAY; SCANDINAVIA; SWEDEN; SWEDISH CITIZEN; VERY ELDERLY; AGE; CLINICAL TRIAL; FEMALE; GENETICS; MALE; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; SCANDINAVIAN AND NORDIC COUNTRIES;

EID: 84922360470     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu442     Document Type: Article

References (36)

1. Eichner JE, Dunn ST, Perveen G, et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487-495.
2. Luo CC, Li WH, Moore MN, et al. Structure and evolution of the apolipoprotein multigene family. J Mol Biol. 1986;187(3): 325-340.
3. Zhang H, Wu LM, Wu J. Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm. 2011;2011:Article ID 949072.
4. Weisgraber KH, Rall SC Jr, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256(17): 9077-9083.
5. Jofre-Monseny L, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res. 2008;52(1):131-145.
6. Mahley RW, Huang Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron. 2012; 76(5):871-885.
7. Minihane AM, Jofre-Monseny L, Olano-Martin E, et al. ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc. 2007;66(2):183-197.
8. Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006; 31(8):445-454.
9. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43(8): 1467-1472.
10. Frisoni GB, Manfredi M, Geroldi C, et al. The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent. J Neurol Neurosurg Psychiatry. 1998;65(1):103-106.
11. Ward A, Crean S, Mercaldi CJ, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1-17.
12. Blanché H, Cabanne L, Sahbatou M, et al. A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III. 2001;324(2):129-135.
13. Cauley JA, Eichner JE, Kamboh MI, et al. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol. 1993;10(1):27-34.
14. McKay GJ, Silvestri G, Chakravarthy U, et al. Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol. 2011;173(12): 1357-1364.
15. Payami H, Zhu M, Montimurro J, et al. One step closer to fixing association studies: evidence forage-and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. Hum Genet. 2005;118(3-4):322-330.
16. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49(2):338-349.
17. Gerdes LU. The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin Chem Lab Med. 2003;41(5):628-631.
18. Fullerton SM, Clark AG, Weiss KM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67(4):881-900.
19. Egert S, Rimbach G, Huebbe P. ApoE genotype: from geographic distribution to function and responsiveness to dietary factors. Proc Nutr Soc. 2012;71(3):410-424.
20. Gerdes LU, Jeune B, Ranberg KA, et al. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene, " not a "longevity gene". Genet Epidemiol. 2000;19(3):202-210.
21. Eisenberg DT, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol. 2010;143(1):100-111.
22. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE∗4 a 'thrifty' allele? Ann Hum Genet. 1999;63(Pt 4):301-310.
23. Strandhagen E, Berg C, Lissner L, et al. Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol. 2010;25(3):163-172.
24. Bengtsson C, Blohmé G, Hallberg L, et al. The study of women in Gothenburg 1968-1969-a population study. General design, purpose and sampling results. Acta Med Scand. 1973;193(4): 311-318.
25. Karlsson B, Klenfeldt IF, Sigström R, et al. Prevalence of social phobia in non-demented elderly from a Swedish population study. Am J Geriatr Psychiatry. 2009;17(2):127-135.
26. Andersson M, Guo X, Borjesson-Hanson A, et al. A population-based study on dementia and stroke in 97 year olds. Age Ageing. 2012;41(4):529-533.
27. Jacobsen R, Martinussen T, Christiansen L, et al. Increased effect of the ApoE gene on survival at advanced age in healthy and long-lived Danes: two nationwide cohort studies. Aging Cell. 2010;9(6):1004-1009.
28. Hjelmborg J, Iachine I, Skytthe A, et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119(3):312-321.
29. Bojanowski CM, Shen D, Chew EY, et al. An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen. 2006; 47(8):594-602.
30. Baird PN, Guida E, Chu DT, et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(5):1311-1315.
31. Simonelli F, Margaglione M, Testa F, et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res. 2001;33(6):325-328.
32. Zareparsi S, Reddick AC, Branham KE, et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci. 2004;45(5):1306-1310.
33. Lucotte G, Loirat F, Hazout S. Pattern of gradient of apolipoprotein E allele ∗4 frequencies in western Europe. Hum Biol. 1997;69(2):253-262.
34. Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4): 463-471.
35. Hendrie HC, Murrell J, Gao S, et al. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006;20(3 suppl 2): S42-S46.
36. Börjesson-Hanson A, Gustafson D, Skoog I. Five-year mortality in relation to dementia and cognitive function in 95-year-olds. Neurology. 2007;69(22):2069-2075.